Table 2.

Changes in hematologic parameters in the study groups.

Parameters	Eprex	Pastopoitin	p-Value
Hb (g/dL)
Baseline	8.48 ± 1.14	8.47 ± 0.94	0.11
Endpoint	9.81 ± 1.21a	9.5 ± 1.25a	0.25
Hct (%)
Baseline	27.41 ± 2.96	27.44 ± 2.86	0.64
Endpoint	31.82 ± 4.19a	31.89 ± 3.11a	0.06
RBC (million/mm3)
Baseline	3.12 ± 0.45	3.13 ± 0.38	0.38
Endpoint	3.77 ± 0.68a	3.71 ± 0.43a	0.17
Platelet (1000/mL)
Baseline	197.03 ± 88.28	203.86 ± 77.9	0.53
Endpoint	186.18 ± 66.63	228.33 ± 71.78	0.18
MCV (fL)
Baseline	87.3 ± 7.41	86.61 ± 7.71	0.3
Endpoint	86.16 ± 10.61	86.98 ± 7.23	0.65
MCH (pg)
Baseline	27.16 ± 3.01	26.72 ± 2.63	0.19
Endpoint	27.76 ± 10.35	26.04 ± 2.48	0.1
MCHC (pg)
Baseline	30.83 ± 2.06	30.81 ± 1.99	0.06
Endpoint	30.70 ± 2.11	29.98 ± 1.71	0.38
WBC (103/mm3)
Baseline	6.1 ± 2.45	6.52 ± 1.84	0.23
Endpoint	5.99 ± 1.55	6.81 ± 1.72	0.45
RDW (%)
Baseline	14.39 ± 2.18	14.4 ± 1.7	0.1
Endpoint	14.03 ± 1.88	14.46 ± 1.74	0.34
Reticulocyte (%)
Baseline	1.18 ± 0.46	1.35 ± 0.67	0.04
Endpoint	1.18 ± 0.55	1.32 ± 0.61	0.37

^aSignificant difference versus baseline value (p < 0.05). Hb: hemoglobin; Hct: hematocrit; RBC: red blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; WBC: white blood cell; RDW: red blood cell distribution width.